Drug General Information
Drug ID
D0T9LR
Former ID
DNCL003801
Drug Name
Liprotamase
Synonyms
LY3031642
Indication Cystic fibrosis [ICD9: 277; ICD10:E84] Phase 3 [522063]
Company
Lilly
Target and Pathway
Target(s) Pancreatic alpha-amylase Target Info Modulator [549848]
Triacylglycerol lipase, pancreatic Target Info Modulator [549848]
Chymotrypsin Target Info Modulator [549848]
BioCyc Pathway Triacylglycerol degradation
Retinol biosynthesis
KEGG Pathway Glycerolipid metabolism
Metabolic pathways
Pancreatic secretion
Fat digestion and absorption
Vitamin digestion and absorption
Reactome Retinoid metabolism and transport
WikiPathways Visual phototransduction
Lipid digestion, mobilization, and transport
References
Ref 522063ClinicalTrials.gov (NCT00500084) Phase III ALTU-135 CP Safety Trial. U.S. National Institutes of Health.
Ref 549848Clinical pipeline report, company report or official report of Anthera Pharmaceuticals.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.